DENTSPLY SIRONA Inc. provided earnings guidance for the year 2024. For the period, the company anticipated organic sales growth in the range of flat to up 1.5%. The Company is revising its anticipated reported sales to a new range of $3.91 billion to $3.97 billion, due to an additional estimated foreign currency translation headwind of $50 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.29 USD | -0.31% | +1.44% | -20.51% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.51% | 5.87B | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- XRAY Stock
- News DENTSPLY SIRONA Inc.
- DENTSPLY SIRONA Inc. Provides Earnings Guidance for the Year 2024